Creative Biolabs is at the forefront of creating stem cell therapy, working with researchers to make new scientific advancements.

Induced pluripotent stem cells (iPSCs) contain the unprecedented possibility of differentiating into almost every cell in the body, which holds vast avenues for disease studying and developing novel therapies. Nonetheless, iPSC-based cell therapy is presently problematic. Issues like low reprogramming efficiency, genomic instability, risk of tumorigenicity, and failure in controlling differentiation encompass significant setbacks.

Arecor Therapeutics plc
(“Arecor” or the “Company”)

ARECOR ESTABLISHES PARTNERSHIP WITH SKYE BIOSCIENCE TO DEVELOP ENHANCED FORMULATION OF OBESITY CANDIDATE NIMACIMAB

- Proprietary formulation technology being applied to potentially enhance properties of nimacimab

Dozens of pharmaceutical companies and tech start-ups came together on Wednesday (14 May), to celebrate the one-year anniversary of a ‘super hub’ they have used to help accelerate their business. 

The Deloitte Life Sciences Catalyst business lounge in Cambridge has helped hundreds of local and regional start-ups across the life sciences industry access a boardroom meeting space and state-of-the-art innovation hub for free. 

In an informative original blog - Amsbio reports how researchers at the University of Exeter Medical School have shed light on the role of microRNA - miR-483-5p in attenuating the detrimental effects of stress on brain function and anxiety-related behaviors.

• Established biotech leader with over 20 years’ experience including at OXB and LifeArc driving commercialization to support CGT downstream manufacturing
• Michele Pedrocchi PhD appointed as Non-Executive Chair of the Board of Directors

Researchers at the John Innes Centre at Norwich Research Park have helped to solve a historical puzzle that could revolutionise the breeding of the humble pea and other legumes leading to improvements in their nutritional value and lessening the reliance on pesticides.

Global drug development consultancy Boyds has appointed a Vice President of Regulatory Affairs in response to growing demand for its specialist services and expertise.